BluGlass Limited (ASX:BLG), founded in 2005 and headquartered in Silverwater, Australia, develops and commercializes proprietary remote plasma chemical vapor deposition (RPCVD) technology for manufacturing gallium nitride (GaN) semiconductor devices; the company provides custom and volume-produced GaN laser diodes and LEDs across wavelengths from 405nm to 525nm in single- and multi-mode configurations, along with foundry services, epitaxial structures, gain chips, and end-to-end design, fabrication, and packaging solutions for industrial, defense, display, scientific, quantum, biotech, and space applications; operations span Australia and the United States, with facilities in Sydney and Nashua, New Hampshire.
BluGlass serves global markets including government agencies, defense primes, OEMs, research institutes, and enterprises such as Collins Aerospace, Infleqtion, Nvidia, NASA, DARPA, the US Army, and the Indian Ministry of Defence.
In recent developments, the company receives initial purchase orders for GaN gain chips from Collins Aerospace and Infleqtion in 2025 to support quantum systems and defense applications; appoints Omer Granit as independent non-executive director and later executive chair to bolster US commercialization efforts; secures contracts including with North Carolina State University under the US Department of Defense's Microelectronics Commons CLAWS Hub and the Indian Department of Defence; completes acquisition of GaNWorks Foundry assets and a Silicon Valley laser diode facility lease and equipment for US$2.5 million to in-house fabrication processes; commissions its largest commercial-scale RPCVD platform, the BLG-500; proposes share consolidation at its forthcoming annual general meeting; and reports a project pipeline exceeding US$100 million across 30 programs with quarterly revenue of A$1.75 million.